P

Inventor

WARRIER JAYAKUMAR SANKARA

IN19 patents
⚠️ This page may combine multiple inventors who share the name “WARRIER JAYAKUMAR SANKARA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

15 patents
US9221796B2Dec 29, 2015

Selective NR2B antagonists

BRISTOL MYERS SQUIBB CO5 citations72
US10669272B2Jun 2, 2020

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO4 citations70
US8722670B2May 13, 2014

Selective NR2B antagonists

BRISTOL MYERS SQUIBB CO2 citations62
US10954225B2Mar 23, 2021

Selective NR2B antagonists

BRISTOL MYERS SQUIBB CO0 citations60
US10336761B2Jul 2, 2019

TGFβ receptor antagonist

BRISTOL MYERS SQUIBB CO1 citations60
US11713316B2Aug 1, 2023

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations59
US10961229B2Mar 30, 2021

Selective NR2B antagonists

BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations59
US10344020B2Jul 9, 2019

Selective NR2B antagonists

BRISTOL MYERS SQUIBB CO1 citations59
US12492172B2Dec 9, 2025

Substituted quinazolinyl compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations51
US12454531B2Oct 28, 2025

Substituted piperazine derivatives useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations51
US11964973B2Apr 23, 2024

Substituted bicyclic compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations50
US10501451B2Dec 10, 2019

Selective NR2B antagonists

BRISTOL MYERS SQUIBB CO0 citations50
US10961239B2Mar 30, 2021

TGF beta receptor antagonists

BRISTOL MYERS SQUIBB CO0 citations49
US11584747B2Feb 21, 2023

Substituted pyridopyrimidinonyl compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations48

RIGEL PHARMACEUTICALS INC

4 patents